Vira Regen Inc.
Vira Regen is a regenerative biotech company pioneering a new class of gene-specific bioelectronic medicines designed to accelerate the body’s natural healing processes. By harnessing the body’s bioelectric network and genetic signaling pathways, the company is developing noninvasive electroceutical therapies targeting bone fracture healing, musculoskeletal injuries, osteoarthritis, osteoporosis, and cancer. Focused on addressing the root causes of disease and tissue damage, Vira Regen aims to redefine regenerative medicine through precision bioelectric therapeutics that promote faster, more effective recovery and tissue regeneration.
Industries
Nr. of Employees
small (1-50)
Vira Regen Inc.
48 S Rio Grande Street, Salt Lake City, Utah, 84101
Vira Regen Inc. is currently seeking investment
Vira Regen Inc. is seeking a seed investment in the range of 1m-5m
Key People
Founder, CEO
VP of Research
Senior Research Scientist
Bioinformatics Scientist
Founder, CEO
VP of Research
Senior Research Scientist
Bioinformatics Scientist
News & Updates
Featured in a recent BioSpace article highlighting the rise of Utah’s biotech ecosystem, Vira Regen was recognized as one of the emerging startups shaping the future of regenerative medicine through bioelectric therapeutics. The article spotlighted founder Kapil Sharma and Vira Regen’s mission to develop noninvasive electrostimulation technologies that activate the body’s natural repair mechanisms to accelerate tissue and bone healing. Supported by a $2 million MTEC award, the company’s lead platform is focused on advancing next-generation bone regeneration solutions for traumatic limb fractures and orthopedic recovery. The feature also emphasized Vira Regen’s role within Altitude Lab, where the company represents a new generation of founder-led biotech startups translating breakthrough science into scalable healthcare innovation.
Featured in a recent BioSpace article highlighting the rise of Utah’s biotech ecosystem, Vira Regen was recognized as one of the emerging startups shaping the future of regenerative medicine through bioelectric therapeutics. The article spotlighted founder Kapil Sharma and Vira Regen’s mission to develop noninvasive electrostimulation technologies that activate the body’s natural repair mechanisms to accelerate tissue and bone healing. Supported by a $2 million MTEC award, the company’s lead platform is focused on advancing next-generation bone regeneration solutions for traumatic limb fractures and orthopedic recovery. The feature also emphasized Vira Regen’s role within Altitude Lab, where the company represents a new generation of founder-led biotech startups translating breakthrough science into scalable healthcare innovation.